These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8997474)

  • 1. Lipoprotein disorders in women: which women are the best candidates for hormone replacement therapy?
    Plushner SL
    Ann Pharmacother; 1997 Jan; 31(1):98-107. PubMed ID: 8997474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary management of hyperlipidemia in women.
    Mosca LJ
    J Womens Health Gend Based Med; 2002 Jun; 11(5):423-32. PubMed ID: 12165159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of estrogens and progestins.
    LaRosa JC
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):140S-146S. PubMed ID: 7958008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestins and androgens.
    Whitehead M
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):161S-167S. PubMed ID: 7958012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of lipid-lowering treatment in postmenopausal women.
    LaRosa JC
    Drugs Aging; 2002; 19(8):595-604. PubMed ID: 12207553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal replacement and lipid changes in postmenopausal women.
    Limpaphayom K; Taechakraichana N; Jaisamrarn U
    J Med Assoc Thai; 1996 Jan; 79(1):10-5. PubMed ID: 8867395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trials of the effects of drugs and hormones on lipids and lipoproteins.
    Mann WA; Windler E; Beil FU; Greten H
    Curr Opin Lipidol; 1995 Dec; 6(6):354-9. PubMed ID: 8750247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of hormone replacement therapy on hyperlipidemia].
    Honjo H; Tanaka K
    Nihon Rinsho; 1999 Dec; 57(12):2848-53. PubMed ID: 10638224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micronized fenofibrate: a new fibric acid hypolipidemic agent.
    Guay DR
    Ann Pharmacother; 1999 Oct; 33(10):1083-103. PubMed ID: 10534222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
    Burkman RT
    Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy.
    Kanda T; Ichikawa S; Sumino H; Sakamaki T; Nakamura T; Tsukui S; Nara M; Kobayashi I; Tamura J
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):179-85. PubMed ID: 11484873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease and dyslipidemia in women.
    Welty FK
    Arch Intern Med; 2001 Feb; 161(4):514-22. PubMed ID: 11252110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases.
    Barrett-Connor E
    Am J Med; 1993 Nov; 95(5A):40S-43S. PubMed ID: 8256794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.